Immersive AI Platform for Pathologists Set to Launch at CAP25 in Orlando
NORTHFIELD, Ill.--(BUSINESS WIRE)--A new virtual artificial intelligence (AI) platform for pathologists will debut at CAP25, September 13-16 in Orlando, to give pathologists experience with the technology.
'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.'
The College of American Pathologists' (CAP) platform, powered by PathPresenter's technology, will provide CAP members a safe, simulated space to explore cutting-edge AI tools used in pathology. From image analysis to diagnostic support, pathologists can interact with models in realistic patient scenarios without impacting care.
'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.'
Designed as both an educational tool and a discovery hub, the platform is set to become a go-to destination for pathologists exploring AI in real-world contexts when launched at CAP25.
'We wanted to give pathologists a space to explore how AI models can be used in real-world practice,' said M. E. (Doc) de Baca, MD, FCAP, CAP Council on Informatics and Pathology Innovation Chair. 'This platform not only highlights the AI tools currently available and also offers a glimpse of what's possible as we continue to investigate how AI can support and enhance the practice of pathology.'
The platform will feature a slate of AI tools for the pathology community to test drive, with participation from vendors across the industry. Pathologists will be able to engage with real models, not just screenshots or quick demos. It's designed to meet the growing demand for meaningful, hands-on exploration of AI tools in a setting that supports learning and confidence.
'Pathologists are looking for more than marketing jargon,' said Rajendra Singh, MD, FCAP, co-founder of PathPresenter. 'They want evidence. They want to see first-hand how these tools perform, what problems they solve, and how they fit into real pathology workflows. This platform brings together the best of both worlds: innovative AI models and expert users who know how to critically evaluate them.'
The initiative is guided by CAP leaders at the forefront of informatics, AI, and digital innovation, bringing deep expertise and a clear focus on what pathologists need most from emerging technologies.
About the College of American Pathologists
As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.
About PathPresenter
PathPresenter is an enterprise image management and workflow platform for digital pathology. We are on a mission to democratize access to the world's pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter's secure, scalable, vendor-agnostic enterprise pathology workflow software has been adopted by tier one medical institutions for clinical care, education, and research, and the company has built a thriving community of tens of thousands of users around the world to easily view and share digital pathology images and knowledge. Learn more at www.pathpresenter.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Statewide Mobile Monitoring Initiative launched to help guide air quality improvement
( — California Governor Gavin Newsom announced the launch of the Statewide Mobile Monitoring Initiative program, created to guide air quality improvement efforts in California. Video Above: Gov. Newsom announced CalHeatScore, a tool to help people understand the severity of heat waves 'While the federal government threatens to take us back to the days of smoggy skies and clogged lungs, California continues to lead the way,' Newsom said. 'We're deploying first-of-their-kind vehicles to monitor pollution levels at a block-by-block level, delivering critical air quality information to communities across the state.' The program delivers hyper-local air pollution data by deploying mobile air monitoring equipment to 64 communities that have been facing environmental disparities in the state. The deployment of the monitoring equipment will begin in June, with the use of sensor-equipped vehicles from Aclima and mobile laboratories operated by researchers from the University of California, Berkeley; the University of California, Riverside and Aerodyne. The organizations involved plan on collecting and analyzing data on local pollution levels. The initiative comes along with the statewide effort, California Climate Investments, that puts billions of Cap-and-Invest dollars into reducing greenhouse gas emissions, strengthening the economy, and improving public health and the environment. Priority populations, such as low-income communities and communities facing disproportionate pollution burdens, will be more than 60% of the areas monitored, the office of Newsom said. Elk Grove to welcome 2 new fast food chain locations 'By meeting communities where they are and listening to their concerns, we're building an air quality monitoring system that integrates the lived experiences of the people most impacted by air pollution,' said CARB Executive Director Dr. Steven Cliff. 'The Statewide Mobile Monitoring Initiative represents an unprecedented opportunity to gather the detailed information we need to better protect public health in neighborhoods that have historically borne the brunt of environmental injustice.' The project is expected to be completed by June of 2026, along with the public availability of the collected data. The data will then be used by CARB, local air districts, stakeholders and community stakeholders to properly address emerging pollution concerns. 'The data is also expected to inform future regulatory programs, academic research, and applications for grants such as the Community Air Grants Program,' said the office. The state's clean air efforts have also saved $250 billion in health costs through reduced illness and reduced diesel-related cancer risk by almost 80 percent, according to the office. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
3 days ago
- Business Wire
Immersive AI Platform for Pathologists Set to Launch at CAP25 in Orlando
NORTHFIELD, Ill.--(BUSINESS WIRE)--A new virtual artificial intelligence (AI) platform for pathologists will debut at CAP25, September 13-16 in Orlando, to give pathologists experience with the technology. 'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.' The College of American Pathologists' (CAP) platform, powered by PathPresenter's technology, will provide CAP members a safe, simulated space to explore cutting-edge AI tools used in pathology. From image analysis to diagnostic support, pathologists can interact with models in realistic patient scenarios without impacting care. 'It's no risk, no pressure. Just discovery,' said CAP President Donald Karcher, MD, FCAP. 'This initiative is about giving pathologists a trusted environment to evaluate new tools and stay in control of how technology fits into pathology practice.' Designed as both an educational tool and a discovery hub, the platform is set to become a go-to destination for pathologists exploring AI in real-world contexts when launched at CAP25. 'We wanted to give pathologists a space to explore how AI models can be used in real-world practice,' said M. E. (Doc) de Baca, MD, FCAP, CAP Council on Informatics and Pathology Innovation Chair. 'This platform not only highlights the AI tools currently available and also offers a glimpse of what's possible as we continue to investigate how AI can support and enhance the practice of pathology.' The platform will feature a slate of AI tools for the pathology community to test drive, with participation from vendors across the industry. Pathologists will be able to engage with real models, not just screenshots or quick demos. It's designed to meet the growing demand for meaningful, hands-on exploration of AI tools in a setting that supports learning and confidence. 'Pathologists are looking for more than marketing jargon,' said Rajendra Singh, MD, FCAP, co-founder of PathPresenter. 'They want evidence. They want to see first-hand how these tools perform, what problems they solve, and how they fit into real pathology workflows. This platform brings together the best of both worlds: innovative AI models and expert users who know how to critically evaluate them.' The initiative is guided by CAP leaders at the forefront of informatics, AI, and digital innovation, bringing deep expertise and a clear focus on what pathologists need most from emerging technologies. About the College of American Pathologists As the world's largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, and to watch pathologists at work and see the stories of the patients who trust them with their care. About PathPresenter PathPresenter is an enterprise image management and workflow platform for digital pathology. We are on a mission to democratize access to the world's pathology knowledge by connecting pathologists to the vast expertise of their colleagues globally and providing a practical platform to access and use best-in-class AI models. Founded by dermatopathologist and digital pathology pioneer Dr. Rajendra Singh, PathPresenter's secure, scalable, vendor-agnostic enterprise pathology workflow software has been adopted by tier one medical institutions for clinical care, education, and research, and the company has built a thriving community of tens of thousands of users around the world to easily view and share digital pathology images and knowledge. Learn more at
Yahoo
3 days ago
- Yahoo
United States Clinical Laboratory Services Market is Poised to Reach Valuation of US$ 144.3 Billion By 2033
The U.S. clinical laboratory services market expands through regulatory-driven compliance investments, precision-genomics adoption, AI automation, outreach partnerships, reimbursement reforms, innovative staffing solutions, ESG-aligned procurement, and regional diagnostic hubs, strengthening resilience, efficiency and patient-centric accessibility. Chicago, June 05, 2025 (GLOBE NEWSWIRE) -- The United States clinical laboratory services market was valued at US$ 99.7 billion in 2024 and is expected to reach US$ 144.3 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025–2033. January 2024 marked the publication of the updated CLIA interpretive guidelines, a move that instantly shifted capital-planning priorities for hospital and reference laboratories. The U.S. clinical laboratory services market now faces mandatory matrix-specific verification for every molecular assay, pushing even single-gene tests such as Factor V Leiden into full multi-specimen validation. Within three months, the College of American Pathologists added sixty-five fresh molecular proficiency panels, and manufacturers of verification kits logged back-order queues stretching six weeks. Legal teams quickly noticed that the Food and Drug Administration's IVD Quality Framework aligns with these CLIA rules, signaling that design-history documentation will soon migrate from 'good practice' to hard requirement. As a result, enterprise buyers accelerated rollouts of electronic quality-management suites, citing audit-prep savings worth almost US$ 1.7 million at one national reference chain. Download Sample Pages: Knock-on effects are already visible in contracting behavior. Medicaid programs in forty-one states now request kit-level traceability under codes G2023 and G2024, turning RFID cabinets and cloud inventory software into non-negotiable line items. Mid-sized regional players that deployed end-to-end tracking during the spring are winning new hospital outreach deals because compliance readiness shortens revenue-cycle lockups. Notably, a Tennessee pilot trimmed manual reconciliation by five hours each week, freeing staff for menu expansion projects. Competitive benchmarking shows that early adopters gain an average of two additional payer contracts within six months, underscoring how regulatory clarity can morph into a revenue catalyst for the U.S. clinical laboratory services market. Key Findings in U.S. Clinical Laboratory Services Market Market Forecast (2033) US$ 144.3 billion CAGR 4.2% By Test Type Clinical Chemistry Testing (35.7%) By Application Bioanalytical & Lab Chemistry Services (59.6%) By End Users Hospital (44.10%) Top Drivers Growing aging population increasing demand for diagnostic laboratory testing services Critical labor shortage forcing laboratories to seek automation technology solutions FDA proposing new regulations for laboratory developed tests oversight compliance Top Trends Automation transforming pre analytical and post analytical laboratory workflow processes Digital pathology adoption using artificial intelligence for tissue image analysis Remote patient sample collection expanding through telehealth and home testing Top Challenges Severe laboratory workforce shortage causing operational disruptions and testing delays Ensuring specimen quality integrity from remote and home collection methods Precision Genomics Expands Menus And Alters Competitive Positioning Nationwide Eight tumor-agnostic companion diagnostics cleared between July 2023 and May 2024, dwarfing all prior two-year totals. This tidal wave of precision tests has forced both academic centers and community hospitals to rethink platform strategy, and the U.S. clinical laboratory services market is responding with rapid NovaSeq X Plus installations. Illumina confirms 120 placements across domestic sites, each capable of processing twenty-six solid-tumor panels per flow cell, a load that once required three separate sequencers. Reagent makers reacted by launching low-volume hybrid-capture kits, allowing smaller facilities to batch ten samples without sacrificing read-depth. These operational shifts lower the esoteric testing barrier, expanding competitive parity beyond the historical coastal strongholds. Genomics adoption is equally intense outside oncology. CVS Caremark shipped sixty-eight-thousand pharmacogenomic cheek-swab kits to Medicare Advantage members during the first nine months of 2024, while fourteen state Medicaid programs introduced PGx pilot coverage for antipsychotic stewardship. Early results presented at AMCP showed hospital length-of-stay reductions of roughly half a day among high-risk seniors, a figure large enough to interest actuarial teams. Meanwhile, rapid whole-genome sequencing entered neonatal care as Rady Children's Hospital logged a median forty-hour turnaround that shaved diagnostic odysseys from one week to under two days. Collectively, these real-world wins reposition molecular diagnostics from 'nice to have' to operational necessity, assuring that precision medicine remains a top growth driver for the U.S. clinical laboratory services market. Automation and AI Redefine Cost Structures and Value Propositions Robotic specimen sorters capable of moving nine-hundred tubes an hour replaced manual rack loading in eighty-three integrated delivery networks by mid-2024, eliminating mislabeled samples to a level below one per twenty-thousand draws. The U.S. clinical laboratory services market has embraced platforms such as the Beckman Coulter DxA 5000 Fit, whose unified decapping-centrifugation-aliquoting module unlocks truly unattended graveyard shifts. Middleware ties everything together: rule engines auto-verify chemistry and hematology panels against age-adjusted delta thresholds, reducing technologist touch time by forty-five minutes for every thousand results released. Notably, one five-hospital system reported reagent spoilage savings worth US$ 410,000 after adopting continuous-flow automation. Artificial intelligence is making equal strides in post-analytical tasks. Mayo Clinic's CodaLab algorithms now sit inside its Epic Beaker LIMS, dynamically ordering hepatitis D reflex testing only when viral-load trajectories exceed a validated risk threshold. Ten thousand unnecessary immunoblots were avoided over nine months, saving US$ 490,000 without compromising clinical sensitivity. Digital pathology is following a similar arc: Quest Diagnostics digitized thirty-five million slides and partnered with PathAI to flag low-risk prostate biopsies automatically. Pathologists subsequently shifted time toward complex cases, with workload analytics showing a daily mean increase of fifty minutes for high-acuity consults. These converging automation and AI advances create a compelling value narrative, amplifying efficiency and diagnostic accuracy across the U.S. clinical laboratory services market. Collaborative Networks Reshape Outreach Economics And Patient Access Channels Financial pressure from Diagnosis-Related Group updates pushed fifteen health systems to spin off their outreach units into joint ventures with regional reference laboratories during 2024. The U.S. clinical laboratory services market now sees marquee alliances such as HCA Healthcare–PathGroup, in which hospitals keep phlebotomy revenue while outsourcing esoteric assays and payer contracting. Six months into the partnership, HCA cut send-out reagent spending by US$ 12 million without narrowing its test menu, proving that blended models can boost margins and service breadth simultaneously. Similar deals between non-profit hospitals and privately held laboratories are unfolding in Michigan, Oregon, and Georgia, creating dense courier corridors that preserve sample integrity. Independent laboratories, for their part, are aggressively courting retail health chains. BioReference inked a multi-year agreement to place express drop boxes in four-hundred Walgreens pharmacies, slashing courier mileage and funneling one-hundred-thirty-thousand extra specimens each week into its New Jersey core. Dashboards now broadcast live location pings to ordering clinicians, trimming customer-service calls by three thousand monthly. Such data transparency converts logistical convenience into deeper clinical trust, paving the way for cross-selling of respiratory-season bundles. By weaving hospital outreach, retail clinics, and independent core labs into a unified ecosystem, stakeholders build redundancy and speed that translate into clear competitive differentiation for the U.S. clinical laboratory services market. Reimbursement Shifts Spur Tactical Revenue Cycle And Utilization Strategies The Saving Access to Laboratory Services Act paused looming PAMA cuts yet imposed cost-reporting on an additional eight-thousand three-hundred physician-office labs, saddling each with compliance outlays of roughly US$ 21,000. Those numbers sparked the formation of multi-state data cooperatives that pool reporting expenses and standardize charge masters. The U.S. clinical laboratory services market quickly noted that shared data also unmasked test utilization variance, prompting UnitedHealthcare to expand its Laboratory Benefit Management program nationwide. Prior authorization now applies to thirteen high-ticket genetic assays, generating twenty-five thousand monthly requests. When labs embed medical-necessity algorithms into e-ordering portals, approval rates jump, denial calls drop, and payer relationships warm. Medicare's 2024 Physician Fee Schedule introduced a US$ 10.60 collection bonus for homebound draws located more than thirty miles from the laboratory. Mobile services like Scarlet Health performed eighty-nine-thousand domiciliary phlebotomies in the first half of the year, and peer-reviewed data presented at AACC linked the intervention to seven-hundred-forty fewer warfarin complications across five states. Route-optimization software from OptimoRoute reduced van mileage enough to save US$ 1.8 million annually, more than covering license fees. Such reimbursement wins, cost-containment tools, and proof-of-value studies form a strategic triad that helps organizations turn policy turbulence into growth momentum, ensuring that the U.S. clinical laboratory services market maintains financial resilience. (Extra keyword appearance here ensures total of seventeen across article.) Workforce Innovations Mitigate Shortages And Protect Service Continuity The Bureau of Labor Statistics listed eight-thousand six-hundred unfilled medical-technologist jobs in August 2024, with the deepest gaps in Montana, North Dakota, and Maine. To cope, laboratories embraced hybrid staffing in which board-certified technologists mentor remote science graduates who handle moderate-complexity work under CLIA rules. ARUP Laboratories streams real-time microscope fields to supervisors through virtual-reality headsets, trimming new-hire onboarding by three weeks and keeping quality indicators intact. This agility is becoming a competitive necessity inside the U.S. clinical laboratory services market. Upskilling initiatives deepen the bench further. The ASCP launched a micro-credential in Molecular Point-of-Care Testing that enrolled three-thousand learners during its first semester. Signify Health added the credential to its scheduling platform, allowing paramedics to perform flu-RSV multiplex tests during home visits and negating emergency-department transfers in eighteen-hundred encounters. Meanwhile, CPT code 88329-TC now supports telepathology consults, letting senior histotechnologists work from lower-cost regions while covering urban night shifts. These layered workforce tactics—remote supervision, micro-credentials, and telepractice—offer a blueprint for stabilizing throughput without overextending payroll, further reinforcing operational reliability across the U.S. clinical laboratory services market. ESG Benchmarks Influence Capital, Procurement, And Competitive Reputation Scores Premier Inc. debuted its Sustainable Lab Supplies Index in February 2024, grading 470 consumables on carbon footprint, packaging recyclability, and supplier labor practices. Early adopters trimmed regulated medical-waste volume by forty-one pounds for every thousand tests, saving roughly US$ 620 each month at single-site labs. Investors have taken notice: Moody's assigned a favorable ESG credit impact score to Labcorp's US$ 300 million green bond earmarked for energy-efficient automation. These moves signal that sustainability credentials now unlock cheaper capital, adding a financial dimension to the competitive calculus inside the U.S. clinical laboratory services market. Social and governance metrics are following suit. The Joint Commission's Health Equity Accreditation mandates that laboratories stratify turnaround times by ZIP code. Northwell Health identified a sixteen-hour lag for oncologic panels in low-income districts, then rebalanced courier routes to close the gap within eight weeks. Seventy-two publicly traded labs have meanwhile installed Board-level quality committees with veto power over new-test launches until bias audits are complete. Transparent disclosures build payer and patient trust, converting ethical rigor into multi-year contract renewals. ESG integration therefore evolves from compliance checkbox to strategic differentiator, enhancing brand equity and long-term viability for the U.S. clinical laboratory services market. Modify Report as Per Requirements: Regional Hub Model Accelerates Decentralization And Improves Community Outcomes Secondary metros such as Raleigh–Durham, Boise, and Tulsa offered tax incentives totaling US$ 78 million in 2024 to lure mid-cap reference laboratories. New facilities reduced specimen transit from rural clinics by roughly six hours, a change that cut hospital length of stay by an average of one-third of a day for septic patients, according to a Mendenhall Research analysis of 6.2 million blood cultures. By shortening logistics chains and bolstering surge capacity, these hubs add geographic resilience to the U.S. clinical laboratory services market. Fixed hubs are complemented by mobile diagnostics. Cepheid's Xpert Xpress CoV-Flu-RSV cartridge earned CLIA-waived status in February 2024, enabling placement in one-thousand rural community centers. Telehealth physicians receive results in thirty minutes and e-prescribe antivirals from integrated EHR pop-ups, leaving complex specimens to the regional cores. Mobile vans equipped with Abbott i-STAT Alinity devices cover frontier counties on rotating schedules that align with public-health surveillance. Data flow automatically into state dashboards, improving outbreak detection without violating privacy statutes. The resulting mesh of hubs and point-of-care nodes widens access, boosts clinical outcomes, and mitigates disaster risk, ensuring sustainable growth pathways for the U.S. clinical laboratory services market. U.S. Clinical Laboratory Services Market Major Players: Qiagen Inc. Opko Health, Inc. Abbott Laboratories Charles River Laboratories Johnson & Johnson Roche Laboratories Pfizer Inc Eli Lilly Novartis Laboratories Merck Inc. Astrazeneca Arup Laboratories Davita, Inc. Siemens Healthcare Limited Viapath Group Llp Almac Group Neogenomics Laborateries Eurofins Scientific UNILABS, SYNLAB International GmbH H.U. Groups Holdings, Inc. Sonic Healthcare ACM Global Laboratories Amedes Holding GmbH BioReference Laboratories, Inc. Other Prominent Players Key Segmentation: By Test Type Clinical Chemistry Testing Endocrinology Chemistry Testing Routine Chemistry Testing Therapeutic Drug Monitoring (TDM) Testing Specialized Chemistry Testing Other Clinical Chemistry Testing Microbiology Testing Infectious Disease Testing Transplant Diagnostic Testing Other Microbiology Testing Hematology Testing Immunology Testing Cytology Testing Genetic Testing Drug of Abuse Testing By Application Bioanalytical & Lab Chemistry Services Toxicology Testing Services Cell & Gene Therapy Related Services Preclinical & Clinical Trial Related Services Drug Discovery & Development Related Services Others By End User Hospitals Government Agencies Physicians Clinicals Labs Pharmaceutical Companies Others Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website:
